Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Colorectal Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

GI Cancer Treatment Continues to Evolve, But Unmet Needs Remain

Cathy Eng, MD, shares her insight on the current paradigm of gastrointestinal cancers, specifically colorectal cancer and hepatocellular carcinoma.

Read More >>

Novel Agent Active Across Heavily Pretreated HER2+ Tumors

Novel Drug Combination Shows Early Activity in Microsatellite Stable CRC

Obesity Impact Draws Increased Scrutiny in GI Malignancies

Real-World Results Reveal Regorafenib Tolerability in mCRC

ESMO 2018: Neoadjuvant Nivolumab Plus Ipilimumab Active in dMMR Early-Stage Colon Cancer

View More Stories >>

View Conference Coverage

2018 San Antonio Breast Cancer Symposium

2018 ASH Annual Meeting

2018 Ruesch Center Symposium

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

Dr. Benson on Considerations for Advanced CRC Treatment

Dr. Strickler on the Importance of Molecular Markers in mCRC

Dr. O'Connor Discusses Regorafenib Dosing in mCRC

Dr. Cercek on Chemotherapy Resistance in dMMR Rectal Cancer

Dr. Benson on the Clinical Utility of cfDNA in Colorectal Cancer

Rationale for Pembrolizumab Plus mFOLFOX6 in Advanced CRC

Dr. O'Connor on Real-World Results With Regorafenib in mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Maintaining Wellness After Treatment

Optimal Duration of Therapy for Stage III Colon Cancer

Treatment Options for High-Risk Stage II Colon Cancer

Efficacy of Adjuvant Therapy in Stage II Colon Cancer

Current Role of Adjuvant Therapy for Colon Cancer

Healthy Lifestyle and Improved Survival Benefit in CRC

Adjuvant Therapy for Stage 2/3 Colorectal Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Immunotherapy in MSS Colorectal Cancer

Immunotherapy Regimens in dMMR/MSI-High Metastatic CRC

Significance of MSI Status and TMB in Metastatic CRC

Triplet Regimens in BRAF-Mutant Metastatic CRC

Future Management of Metastatic Colorectal Cancer

Emerging Therapy in Metastatic Colorectal Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Treatment Goals in Refractory mCRC

$Treatment Goals in Refractory mCRC$
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now

Featured Video

Novel Combination Approaches for Metastatic Kidney Cancer